- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Nicole Fukuoka is an Associate in King & Spalding’s Trial and Global Disputes practice group. Nicole defends Fortune 100 and other large companies in a wide range of complex litigation matters, including automotive, toxic tort and other product liability cases.
Ms. Fukuoka graduated magna cum laude from the University of Southern California. She earned her Juris Doctor degree from Emory University School of Law, where she served as Editor-in-Chief of the Emory Corporate Governance & Accountability Review.
Credentials
J.D., Emory University School of Law, honors
B.A. Journalism, University of Southern California, magna cum laude
California
News
Cases & Deals
January 6, 2020
Johnson & Johnson Wins Complete Summary Judgment in Talc Litigation
Cases & Deals
April 5, 2019
King & Spalding Team Achieves Defense Verdict in Johnson & Johnson Talcum Powder Trial
Recognition
March 15, 2018
Daily Journal Names King & Spalding Defense Verdict as One of 2017’s Top Verdicts in California
News
Cases & Deals
January 6, 2020
Johnson & Johnson Wins Complete Summary Judgment in Talc Litigation
Cases & Deals
April 5, 2019
King & Spalding Team Achieves Defense Verdict in Johnson & Johnson Talcum Powder Trial
Recognition
March 15, 2018
Daily Journal Names King & Spalding Defense Verdict as One of 2017’s Top Verdicts in California
News
Cases & Deals
January 6, 2020
Johnson & Johnson Wins Complete Summary Judgment in Talc Litigation
Cases & Deals
April 5, 2019
King & Spalding Team Achieves Defense Verdict in Johnson & Johnson Talcum Powder Trial
Recognition
March 15, 2018
Daily Journal Names King & Spalding Defense Verdict as One of 2017’s Top Verdicts in California
Credentials
J.D., Emory University School of Law, honors
B.A. Journalism, University of Southern California, magna cum laude
California